Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma

ABSTRACT: Patients with early-stage lung adenocarcinoma (LUAD) exhibit different overall survival (OS) rates and immunotherapy responses. Understanding the immune landscape facilitates the personalized treatment of LUAD. The immune cell populations in tumour tissues were quantified to depict the imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Xuanwen, Shi, Run, Zhao, Tianyu, Wang, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297823/
https://www.ncbi.nlm.nih.gov/pubmed/32333046
http://dx.doi.org/10.1007/s00109-020-01908-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297823/
https://www.ncbi.nlm.nih.gov/pubmed/32333046
http://dx.doi.org/10.1007/s00109-020-01908-9

Ejemplares similares